Lupin, Cipla bid for UCB's US generic drugs portfolio: Report
Generic drugmakers Lupin Ltd and Cipla Ltdare among the companies bidding for top Belgian drugmaker UCB SA`s U.S. generic drugs business, a leading dailey reported on Monday, citing unnamed people with knowledge of the matter.
Jun 01, 2015, 18:56 PM IST
'Dr Reddy's in talks to buy UCB India business for $135 million'
Drugmaker Dr Reddy`s Laboratories Ltd is in talks to acquire the Indian operations of Belgian pharmaceutical company UCB SA for about $135 million, said a person with direct knowledge of the matter.
Mar 10, 2015, 19:34 PM IST
